Synthetic Heparin-Binding Growth Factor Analog Formulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There are no known formulations, methods, or kits designed to augment or activate growth factors like FGF-2, BMP-2, or TGF-β for bone or cartilage repair, either endogenously produced or derived from natural or recombinant sources, and no formulations employing synthetic heparin-binding growth factor analogs.
Innovation Solution
A formulation for bone or cartilage repair is developed, including a synthetic heparin-binding growth factor analog with a heparin-binding region, a hydrophobic linker, and a calcium-containing agent, optionally with non-ionic polymers and gelling agents, which can be used in a kit for injectable delivery to osteogenic defects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If synthetic heparin-binding growth factor analogs are used for bone or cartilage repair, then tissue repair effectiveness is improved, but no known formulations or delivery methods exist to activate these growth factors
Solution Approach 1:
The patent introduces calcium-containing agents as intermediary substances that activate synthetic heparin-binding growth factor analogs. The calcium ions serve as a mediator between the growth factor analogs and their target receptors, enabling the formulation to effectively stimulate bone and cartilage repair processes without requiring complex delivery systems.
Solution Approach 2:
The patent utilizes changes in ionic concentration parameters by incorporating calcium-containing agents into the formulation. The calcium ions alter the local chemical environment, enabling activation of the growth factor analogs and enhancing their biological activity for tissue repair applications.
2Productivity
If growth factors are used to stimulate cell growth and differentiation, then osteogenic processes are enhanced, but no formulations exist to augment endogenously produced or recombinant growth factors
Solution Approach 1:
The formulation is designed to work with endogenously produced growth factors already present in the body. The calcium-containing agents and heparin-binding analogs serve to amplify and enhance the activity of these naturally occurring factors, allowing the body's own repair mechanisms to be boosted without requiring external growth factor administration.
3Reliability
If calcium-containing agents are combined with growth factor analogs, then bone repair is enhanced, but the formulation complexity increases
Solution Approach 1:
The calcium-containing agents serve multiple functions within the formulation: they act as activation agents for the growth factor analogs, provide structural support for bone repair, and potentially serve as delivery vehicles. This multi-functionality reduces the need for separate components and simplifies the overall formulation design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation enhances bone and cartilage repair by augmenting cell growth and differentiation, providing a novel composition for tissue repair that includes synthetic heparin-binding growth factor analogs, which are effective in stimulating osteogenic processes.
Implementation Method 1
a heparin-binding region, wherein the HBGFR is a member of the TGF-beta superfamily, the FGF family or the PDGF family
Data Source
AI summary
Formulations, kits and methods for bone or cartilage repair, including treatment of osteogenic defects, including formulations of synthetic heparin-binding growth factor analogs, non-ionic polymers, gelling agents and calcium-containing agents.